Last Update: 30 June 2016
School: The Ohio State University
Genetesis is a privately held medical technology company oriented towards the development of efficient and non-invasive cardiac current density mapping. Our technology utilizes the body’s weak magnetic fields to reconstruct, computationally, areas of high and low electrical conductivity in the heart. Our software, the Genetesis CardioFlux Mapping System, is able to characterize deep sources of current that are consistently missed by the EKG, and does so with the utmost accuracy and 3D visualization. With its noninvasive design, CardioFlux has exciting diagnostic capabilities which will hopefully improve patient safety and physician confidence, with ultimate reduction in cost to the healthcare system.